Valuation — not yet established
No valuation for Immunomic Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($121.9M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Immunomic Therapeutics
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2025 | Early Stage VC | $6.5M | ▮ | ▮ |
| Jan 2024 | Seed Round | $3.0M | ▮ | ▮ |
| Feb 2020 | Later Stage VC | $77.7M | ▮ | ▮ |
| Jul 2018 | Seed Round | $315K | ▮ | ▮ |
| Feb 2017 | Debt | $4.6M | ▮ | ▮ |
How Immunomic Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Immunomic Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Immunomic Therapeutics raised?
- Immunomic Therapeutics has raised $121.9M in total funding across 5 recorded rounds.
- When did Immunomic Therapeutics last raise?
- Immunomic Therapeutics last raised in May 2025 (Early Stage VC), raising $6.5M.